Audiopharma
ActiveSummary
Audiopharma has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €65k and a net result of €3k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 69% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
69
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability44▲+44
Solvency71▼-29
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity ample (current ratio 13.04 against 4.88 in 2024; short-term debt: 7% and cash: 0.7% of total assets), but 54.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
45.9%
Return on assets
2.5%
Age of the figures
9 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-09-2026, 54 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
54 d late
2024
92 d late
2023
68 d late
2022
74 d late
2021
61 d late
2020
19 d late
2019
91 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€65k▲ 5.6%
2024 · €61k
2018: €6k
2019: €5k
2020: €-15k
2021: €5k
2022: €60k
2023: €77k
2024: €61k
2018 → 2025
Total assets
€141k▲ 87.4%
2024 · €75k
2018: €55k
2019: €68k
2020: €42k
2021: €60k
2022: €126k
2023: €107k
2024: €75k
2018 → 2025
Net result
€3k
2024 · €-28k
2018: €106
2019: €-1k
2020: €-20k
2021: €20k
2022: €55k
2023: €17k
2024: €-28k
2018 → 2025
Working capital
€119k▲ 181%
2024 · €42k
2018: €41k
2019: €33k
2020: €15k
2021: €13k
2022: €44k
2023: €54k
2024: €42k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€5k-€60k▲ 1,111%€77k▲ 28.2%€61k▼ 20.1%€65k▲ 5.6%
Operating result€24k-€77k▲ 227%€27k▼ 65.5%€-25k€7k
Net result€20k-€55k▲ 180%€17k▼ 69.3%€-28k€3k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €7k after a loss of €25k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €141k
Fixed assets
€13k ▼ 43.5%
Current assets
€129k ▲ 142%
Equity and liabilities €141k
Equity
€65k ▲ 5.6%
Debt
€76k ▲ 448%
Debt's share of the balance-sheet total rises from 18.5% to 54.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€14k▲
2024 · €-16k
Cash flow
€11k▲
2024 · €-19k
Current ratio
13.04▲
2024 · 4.88
Debt to equity
1.18▲
2024 · 0.23
ROE
5.3%▲
2024 · -45.3%
ROA
2.5%▲
2024 · -36.9%
Interest coverage
2.70▲
2024 · -3.15
Debt ≤ 1 year
€10k▼
2024 · €11k
Debt > 1 year
€67k▲
2024 · €3k
Income taxes
€428▲
2024 · €348
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet
Code20242025
Assets
Total assets20/58€75k€141k▲
Fixed assets21/28€22k€13k▼
Tangible fixed assets22/27€17k€7k▼
Plant, machinery and equipment23€5k€3k▼
Furniture and vehicles24€10k€3k▼
Leasing and similar rights25€2k€1k▼
Financial fixed assets28€5k€5k=
Current assets29/58€53k€129k▲
Amounts receivable within one year40/41€41k€119k▲
Trade receivables40€4k€3k▼
Other amounts receivable41€38k€116k▲
Cash at bank and in hand54/58-€932
Deferred charges and accrued income490/1€12k€9k▼
Equity and liabilities
Total equity and liabilities10/49€75k€141k▲
Equity10/15€61k€65k▲
Contributions10/11€19k€19k=
Reserves13€71k€71k=
Distributable reserves133€71k€71k=
Profit (loss) carried forward14€-28k€-24k▲
Amounts payable17/49€14k€76k▲
Amounts payable after more than one year17€3k€67k▲
Financial debts170/4€3k€67k▲
Amounts payable within one year42/48€11k€10k▼
Current portion of amounts payable after more than one year42€5k€8k▲
Financial debts43€5k-
Credit institutions430/8€5k-
Trade debts44€1k€1k▲
Suppliers440/4€1k€1k▲
Taxes, remuneration and social security45€348€776▲
Taxes450/3€348€776▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€8k▼
Other operating charges640/8€513€1k▲
Non-recurring operating charges66A€3k€746▼
Gross operating margin9900€-12k€16k▲
Operating profit (loss)9901€-25k€7k▲
Financial income75/76B€3k€3k▼
Recurring financial income75€3k€3k▼
Financial charges65/66B€5k€5k▲
Recurring financial charges65€5k€5k▲
Non-recurring financial charges66B-€57
Profit (loss) for the period before taxes9903€-28k€4k▲
Income taxes67/77€348€428▲
Profit (loss) for the period9904€-28k€3k▲
Profit (loss) for the period to be appropriated9905€-28k€3k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-28k€-24k▲
Profit (loss) brought forward from the previous period14P-€-28k
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-09
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 54 days late
2025
31-12
Financial
Back to profitnet €3k
Net result €3k after one loss-making year.
31-12
Financial
Liquidity triplescurrent ratio 13.04
Current ratio from 4.88 to 13.04; short-term debt falls from €11k to €10k.
31-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 92 days late
2024
31-12
Financial
Weakest financial yearnet €-28k ▼265%
Net result drops to €-28k, the lowest in the series; recovery starts the following year.
07-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 68 days late
2023
13-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 74 days late
2022
31-12
Financial
Highest result since 2018net €55k ▲180%
Operating result €77k, net result €55k, both a record.
30-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 61 days late
2021
31-12
Financial
Back to profitnet €20k
Net result €20k after 2 loss-making years.
19-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 19 days late
2020
30-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 91 days late
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genk · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Paesteblookstraat 13600 GenkGround area
781 m²
Building footprint
117 m²
Parcel 71303C0597/00A000, Flanders. Linked by address, not a title deed.
1 establishment unit
Audiopharma
since 20182.272.105.036
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71303C0597/00A000 | Flanders | 781 m² | 1 · 117 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DOC SEBASTIAN LAURENT
BE 1005.495.862
Sivry-Rance · Eq €61,487
DR DONATIENNE DEMULIER
BE 1000.463.542
Vorst · Eq €61,341
TILQUIN CELINE ANESTHESISTE
BE 0742.564.593
Fosses-la-Ville · Eq €61,632
Associatie GZA SA SV Anesthesie, Intensieve Zorgen, en Pijnkliniek
BE 0718.819.290
Antwerpen · Eq €61,655
SONIGRIM
BE 0899.971.344
Villers-la-Ville · Eq €61,713
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 5,458 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded11-01-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.